Comparisons

PrenatalSAFE vs Bitest

Targeted analysis, limited to 5 chromosomes
▪ Low resolution sequencing (reading depth ~1-6 million of sequences)
▪ Analysis limited to 5 chromosomes (21, 18, 13, X, Y)
▪ The algorithm carries out a risk analysis, associating the data obtained from the examination with external data (ex. pregnant woman’s age, ultrasound comparisons), producing a “risk score”
▪ High/Low risk results, similarly to the Bi-Test
▪ Longer reporting times (~10-15 working days)
▪ High percentage of test repetition (4-12%)
▪ Only some commercial tests do not allow the analysis in case of pregnancy by artificial insemination or heterologous
▪ They require a collection of 20 ml of blood and the use of 2 tubes



Comparison with invasive Prenatal Diagnosis

PrenatalSAFE® 3 e 5 tests allow to highlight, respectively, the 71% and the 83.1% of the chromosomal abnormalities observable during pregnancy. With PrenatalSAFE® Plus test the detection rate reaches the 86%

PrenatalSAFE® COMPLETE test represents the highest level of in-depth analysis available today for non-invasive prenatal tests on circulating free DNA in maternal blood. The test allows to measure the 95.5% of chromosomal abnormalities detectable during pregnancy (KaryoPlus level of investigation) reaching a detection rate level very similar to that of the traditional fetal karyotype (96.9%), obtained through invasive prenatal diagnosis techniques. Furthermore the test adds to these potentialities even the ability to detect mutations responsible of severe genetic disorders (association with GeneSafeTM test).

Accuratezza Test
Share: